Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations

J Thorac Cardiovasc Surg. 1997 Apr;113(4):802-4. doi: 10.1016/S0022-5223(97)70244-7.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Antifibrinolytic Agents / therapeutic use*
  • Blood Loss, Surgical / prevention & control*
  • Blood Volume
  • Cardiopulmonary Bypass / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Tranexamic Acid / therapeutic use*

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid